Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Hamon SC"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Wang B; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, NY, 10591, USA., Golubov J; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, NY, 10591, USA., Oswald EM; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, NY, 10591, USA., Poon P; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, NY, 10591, USA., Wei Q; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, NY, 10591, USA., Lett C; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, NY, 10591, USA., Shehadeh F; Division of Infectious Diseases, Department of Medicine, The Brown Alpert Medical School and the Miriam Hospital, Providence, RI, USA; Department of Medicine, Houston Methodist Academic Institute, Houston, TX, 77030, USA., Kaczynski M; Division of Infectious Diseases, Department of Medicine, The Brown Alpert Medical School and the Miriam Hospital, Providence, RI, USA., Felix LO; Division of Infectious Diseases, Department of Medicine, The Brown Alpert Medical School and the Miriam Hospital, Providence, RI, USA; Department of Medicine, Houston Methodist Academic Institute, Houston, TX, 77030, USA., Mishra B; Division of Infectious Diseases, Department of Medicine, The Brown Alpert Medical School and the Miriam Hospital, Providence, RI, USA; Department of Medicine, Houston Methodist Academic Institute, Houston, TX, 77030, USA., Mylona EK; Division of Infectious Diseases, Department of Medicine, The Brown Alpert Medical School and the Miriam Hospital, Providence, RI, USA; Department of Medicine, Houston Methodist Academic Institute, Houston, TX, 77030, USA., Wipperman MF; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, NY, 10591, USA., Chio E; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, NY, 10591, USA., Hamon SC; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, NY, 10591, USA., Hooper AT; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, NY, 10591, USA., Somersan-Karakaya S; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, NY, 10591, USA., Musser BJ; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, NY, 10591, USA., Petro CD; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, NY, 10591, USA., Hamilton JD; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, NY, 10591, USA., Sleeman MA; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, NY, 10591, USA., Kalliolias GD; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, NY, 10591, USA., Mylonakis E; Division of Infectious Diseases, Department of Medicine, The Brown Alpert Medical School and the Miriam Hospital, Providence, RI, USA; Department of Medicine, Houston Methodist Academic Institute, Houston, TX, 77030, USA., Skokos D; Regeneron Pharmaceuticals, Inc., Tarrytown, New York, NY, 10591, USA. Electronic address: Dimitris.Skokos@regeneron.com.
Publikováno v:
EBioMedicine [EBioMedicine] 2024 Oct; Vol. 108, pp. 105334. Date of Electronic Publication: 2024 Sep 12.
Autor:
Wipperman MF; Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States.; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Lin AZ; Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Gayvert KM; Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Lahner B; Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States.; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States.; Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Somersan-Karakaya S; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Wu X; Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Im J; Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Lee M; Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Koyani B; Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Setliff I; Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Thakur M; Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Duan D; Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States.; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Breazna A; Biostatistics and Data Management, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Wang F; Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States.; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Lim WK; Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Halasz G; Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Urbanek J; Biostatistics and Data Management, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Patel Y; General Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Atwal GS; Molecular Profiling & Data Science, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Hamilton JD; Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States.; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Stuart S; Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Levy O; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Avbersek A; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Alaj R; Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Hamon SC; Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, United States.; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States., Harari O; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, United States.
Publikováno v:
ELife [Elife] 2024 Apr 30; Vol. 13. Date of Electronic Publication: 2024 Apr 30.
Autor:
Wipperman MF; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Gayvert KM; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Atanasio A; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Wang CQ; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Corren J; Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, California, USA., Covarrubias A; Clinical Research Division, Jonathan Corren, MD. Inc., Los Angeles, California, USA., Setliff I; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Chio E; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Laws E; Sanofi, Bridgewater, New Jersey, USA., Wolfe K; Sanofi, Bridgewater, New Jersey, USA., Harel S; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Maloney J; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Herman G; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Orengo JM; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Lim WK; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Hamon SC; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., Hamilton JD; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA., O'Brien MP; Regeneron Pharmaceuticals Inc., Tarrytown, New York, USA.
Publikováno v:
Allergy [Allergy] 2024 Apr; Vol. 79 (4), pp. 894-907. Date of Electronic Publication: 2024 Jan 27.
Autor:
Devalaraja-Narashimha K; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Ehmann PJ; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Huang C; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; Wesleyan University, Middletown, CT, USA., Ruan Q; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Wipperman MF; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Kaplan T; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Liu C; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Afolayan S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Glass DJ; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Mellis S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Yancopoulos GD; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Hamilton JD; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., MacDonnell S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Hamon SC; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Boyapati A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Morton L; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
Publikováno v:
Microbes and infection [Microbes Infect] 2023 May; Vol. 25 (4), pp. 105081. Date of Electronic Publication: 2022 Dec 07.
Autor:
Wipperman MF; Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America.; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America., Pogoncheff G; Earable Inc., Boulder, Colorado, United States of America., Mateo KF; Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America., Wu X; Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America., Chen Y; Biostatistics and Data Management, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America., Levy O; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America., Avbersek A; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America., Deterding RR; Earable Inc., Boulder, Colorado, United States of America., Hamon SC; Precision Medicine, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America.; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America., Vu T; Earable Inc., Boulder, Colorado, United States of America., Alaj R; Clinical Outcomes Assessment and Patient Innovation, Global Clinical Trial Services, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America., Harari O; Early Clinical Development & Experimental Sciences, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States of America.
Publikováno v:
PLOS digital health [PLOS Digit Health] 2022 Jun 30; Vol. 1 (6), pp. e0000061. Date of Electronic Publication: 2022 Jun 30 (Print Publication: 2022).